TherapeuticsMD (TXMD) Tax Provisions (2011 - 2025)

TherapeuticsMD (TXMD) posted Tax Provisions of -$32000.0 for Q1 2025, up 89.33% on a QoQ basis from -$300000.0 in Q3 2022.

TherapeuticsMD (TXMD) Tax Provisions (2011 - 2025) Analysis & Trends

TherapeuticsMD's Tax Provisions history runs 3 years deep, the most recent figure standing at -$32000.0 for Q1 2025.

Quarterly Tax Provisions changed N/A year-over-year to -$32000.0 in Q1 2025, while the trailing twelve-month figure through Sep 2025 was -$332000.0 (changed N/A YoY) and the FY2024 annual result came in at -$31000.0, up 27.91% from the prior year.
Tax Provisions was -$32000.0 for Q1 2025 at TherapeuticsMD, up from -$300000.0 in the prior quarter.
Across five years, Tax Provisions topped out at $550000.0 in Q2 2022 and bottomed at -$300000.0 in Q3 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Taxes (Qtr)
1	Haleon	88.07 Bn	86.20 Bn	-	-
2	Teva Pharmaceutical Industries	35.75 Bn	32.01 Bn	1.97 Bn	67.00 Mn
3	Zoetis	31.84 Bn	29.90 Bn	1.62 Bn	157.00 Mn
4	Takeda Pharmaceutical	27.18 Bn	23.12 Bn	4.39 Bn	676.90 Mn
5	United Therapeutics	23.09 Bn	20.93 Bn	648.10 Mn	43.40 Mn
6	RedHill Biopharma	21.32 Bn	21.32 Bn	-	-
7	Viatris	19.96 Bn	18.16 Bn	1.16 Bn	-423.70 Mn
8	Neurocrine Biosciences	17.66 Bn	16.34 Bn	800.70 Mn	48.90 Mn
9	Elanco Animal Health	12.44 Bn	12.02 Bn	785.00 Mn	30.00 Mn
10	TherapeuticsMD	278,799.99	-8.14 Mn	-	-

Download Data